Ikarovec
PrivateLast Round
Series A
Oct 22, 2025
Total Funding Raised
$10.78M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Ikarovec is a biotechnology company that develops novel, multi-cistronic gene therapies for ophthalmic diseases such as age-related macular degeneration and diabetic macular edema.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ikarovec Comparables
Compare Ikarovec with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Atsena Therapeutics | 81% | |
| Beacon Therapeutics | 79% | |
| Frontera Therapeutics | 77% | |
Ikarovec Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 22, 2025 | ||||
| Seed | Oct 23, 2024 | ||||
| Grant | Jun 15, 2020 | ||||
| Seed | Feb 5, 2020 |
Ikarovec Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| GenScript | Grant |
| UK Innovation & Science Seed Fund | Seed |
| LifeArc Ventures | Seed |
| LifeArc | Seed |
| Innovate UK | Grant |
| Parkwalk Advisors | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 72% MoM, from 1.1K to 1.9K.
- Jan 6, 2026
Developing IKAR-003 with VectorBuilder Inc. for disease progression prevention.
Ikarovec Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ikarovec's valuation, stock price, and market status.